Trinity Vascular Technologies
Irvine, United States (US) · Manufacturing and Industry
We built this page from public sources.
Do you work at Trinity Vascular Technologies?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Trinity Vascular Technologies is a Manufacturing and Industry company based in Irvine, United States (US), with 2-10 employees. Trinity Vascular Technologies's profile is verified on Enterprise League.
Overview
Trinity Vascular Technologies is an Irvine, California-based MedTech company revolutionizing vascular access care.
We develop and commercialize a unique triple-action antimicrobial surface platform designed to significantly reduce catheter-related bloodstream infections (CLABSIs) and improve patient safety – a critical challenge costing hospitals billions annually.
Our innovative technology combines a zwitterionic anti-fouling surface with integrated FDA-approved antimicrobial agents, creating a synergistic dual-mechanism design that effectively repels bacteria and prevents biofilm formation.
Trinity Vascular Technologies is currently raising a seed round to accelerate regulatory execution, manufacturing scale-up, and market entry, targeting the ~$1.7B U.S. vascular access serviceable obtainable market. We are strategically positioned to capitalize on the growing demand for effective infection prevention solutions within the vascular access space, with a clear regulatory pathway and validated clinical foundations.
We develop and commercialize a unique triple-action antimicrobial surface platform designed to significantly reduce catheter-related bloodstream infections (CLABSIs) and improve patient safety – a critical challenge costing hospitals billions annually.
Our innovative technology combines a zwitterionic anti-fouling surface with integrated FDA-approved antimicrobial agents, creating a synergistic dual-mechanism design that effectively repels bacteria and prevents biofilm formation.
Trinity Vascular Technologies is currently raising a seed round to accelerate regulatory execution, manufacturing scale-up, and market entry, targeting the ~$1.7B U.S. vascular access serviceable obtainable market. We are strategically positioned to capitalize on the growing demand for effective infection prevention solutions within the vascular access space, with a clear regulatory pathway and validated clinical foundations.
Contact Details
contact@trinityvascular.com
Irvine, United States (US), 5270 California Ave
Company Type
Private Limited Company
Employees
2-10
Companies teams usually look at after Trinity Vascular Technologies
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.